Fady Ibraham Malik - 09 Apr 2024 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Signature
/s/ John Faurescu, attorney-in-fact for Dr. Malik
Issuer symbol
CYTK
Transactions as of
09 Apr 2024
Net transactions value
-$2,232,122
Form type
4
Filing time
09 Apr 2024, 16:38:05 UTC
Previous filing
18 Mar 2024
Next filing
15 Apr 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $190,795 +28,605 +20% $6.67* 171,172 09 Apr 2024 Direct
transaction CYTK Common Stock Sale $2,125,638 -28,605 -17% $74.31 142,567 09 Apr 2024 Direct
transaction CYTK Common Stock Sale $297,280 -4,000 -2.8% $74.32 138,567 09 Apr 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -28,605 -100% $0.000000* 0 09 Apr 2024 Common Stock 28,605 $6.67 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).